Metraipolis › archive › dc_5187d67129c8
Critical Quality Attribute Investigation and Analytical Method Establishment for Glyco-Site-Specific Anti-HER2 Bispecific ADC — Europe PMC PMID:42797539
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42797539
- DOI
- 10.3390/ph19091495
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-08T01:45:56.450Z
- SHA-256 of the archived text
1bf53257f837edd1463196dcdcd2de873433b83fea112e6dc0152cad7b28d84a- Stable URL of this page
https://metraipolis.com/documento/dc_5187d67129c8
How to cite
Critical Quality Attribute Investigation and Analytical Method Establishment for Glyco-Site-Specific Anti-HER2 Bispecific ADC — Europe PMC PMID:42797539 — Europe PMC (en), https://europepmc.org/article/MED/42797539 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5187d67129c8 (Metraipolis archive dc_5187d67129c8, sha256 1bf53257f837edd1463196dcdcd2de873433b83fea112e6dc0152cad7b28d84a)
BibTeX
@misc{dc5187d67129c8,
title = {Critical Quality Attribute Investigation and Analytical Method Establishment for Glyco-Site-Specific Anti-HER2 Bispecific ADC — Europe PMC PMID:42797539},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42797539},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5187d67129c8; sha256 1bf53257f837edd1463196dcdcd2de873433b83fea112e6dc0152cad7b28d84a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42797539. Agents can read the archived copy with the MCP tool read_document.